18F-FDG PET radiomics-based machine learning model for differentiating pathological subtypes in locally advanced cervical cancer

Author:

Liu Huiling1,Lao Mi2,Chang Cheng1,Zhang Yalin1,Yin Yong3,Wang Ruozheng1

Affiliation:

1. The Third Affillated Teaching Hospital of Xinjiang Medical University

2. Binzhou People's Hospital

3. Shandong Cancer Hospital and Institute

Abstract

Abstract Purpose To determine diagnostic performance of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and computed tomography (CT) radiomics-based machine learning (ML) for classification of cervical adenocarcinoma (AC) and squamous cell carcinoma (SCC). Methods A total of 195 patients with locally advanced cervical cancer were enrolled in this study, and randomly allocated to training cohort (n = 136) and validation cohort (n = 59) in a ratio of 7:3. Radiomics features were extracted from pretreatment 18F-FDG PET/CT and selected by the Pearson correlation coefficient and the least absolute shrinkage and selection operator regression analysis. Six ML classifiers were trained and validated, and the best-performing classifier was selected based on accuracy, sensitivity, specificity, and area under the curve (AUC). The performance of different models was assessed and compared using the DeLong test. Results Five PET and one CT radiomics features were selected and incorporated into the ML classifiers. The PET radiomics model constructed based on the lightGBM algorithm had an accuracy of 0.915 and an AUC of 0.851 (95% CI, 0.715–0.986) in the validation cohort, which were higher than that of the CT radiomics model (accuracy: 0.661; AUC: 0.513 [95% CI, 0.339–0.688]). The DeLong test revealed no significant difference in AUC between the combined radiomics model and the PET radiomics model in both the training cohort (P = 0.347) and the validation cohort (P = 0.776). Conclusions The 18F-FDG PET radiomics model can be used as a clinically applicable tool for differentiating pathological subtypes in patients with locally advanced cervical cancer.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3